- Home
- NEOV vs BIOA Comparison
NEOV vs BIOA Comparison
Compare NEOV & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- BIOA
- Stock Information
- Founded
- NEOV 2018
- BIOA 2015
- Country
- NEOV United States
- BIOA United States
- Employees
- NEOV N/A
- BIOA N/A
- Industry
- NEOV Industrial Machinery/Components
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- NEOV Miscellaneous
- BIOA Health Care
- Exchange
- NEOV Nasdaq
- BIOA Nasdaq
- Market Cap
- NEOV 153.9M
- BIOA 175.7M
- IPO Year
- NEOV N/A
- BIOA 2024
- Fundamental
- Price
- NEOV $5.72
- BIOA $5.56
- Analyst Decision
- NEOV Hold
- BIOA Hold
- Analyst Count
- NEOV 1
- BIOA 4
- Target Price
- NEOV N/A
- BIOA $5.67
- AVG Volume (30 Days)
- NEOV 376.6K
- BIOA 184.5K
- Earning Date
- NEOV 11-07-2025
- BIOA 11-06-2025
- Dividend Yield
- NEOV N/A
- BIOA N/A
- EPS Growth
- NEOV N/A
- BIOA N/A
- EPS
- NEOV N/A
- BIOA N/A
- Revenue
- NEOV $8,426,835.00
- BIOA $3,863,000.00
- Revenue This Year
- NEOV $121.51
- BIOA N/A
- Revenue Next Year
- NEOV $32.79
- BIOA N/A
- P/E Ratio
- NEOV N/A
- BIOA N/A
- Revenue Growth
- NEOV 218.59
- BIOA N/A
- 52 Week Low
- NEOV $1.80
- BIOA $2.88
- 52 Week High
- NEOV $6.11
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- NEOV 64.24
- BIOA 60.29
- Support Level
- NEOV $4.65
- BIOA $5.55
- Resistance Level
- NEOV $5.05
- BIOA $6.00
- Average True Range (ATR)
- NEOV 0.45
- BIOA 0.28
- MACD
- NEOV 0.01
- BIOA 0.03
- Stochastic Oscillator
- NEOV 89.56
- BIOA 61.69
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.